Replies to post #226038 on Amarin Corp Plc (AMRN)

[SonamKapoor]

topic 2 a fib/flutter/bleeding - panelist clinicians seemed fine with results. suggested risk can be managed with labeling & post marketing surveillance monitoring project.

now topic 3. then a break and topic 4 afterwards.